Investigating the role of a specific protein variant in blood cancer development
Role of the TET1 short isoform in MDS development and maintenance
This study is looking at how a shorter version of a protein called TET1 might play a role in causing Myelodysplastic Syndrome (MDS) and other blood cancers, by examining bone marrow cells from patients to better understand how it affects blood cell production, which could help improve diagnosis and treatment options for these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11009597 on NIH RePORTER |
What this research studies
This research focuses on understanding how a short version of the TET1 protein may contribute to the development of Myelodysplastic Syndrome (MDS) and other blood cancers. The researchers will explore the mechanisms by which this protein variant affects hematopoietic stem cells, which are crucial for producing blood cells. By analyzing bone marrow cells from patients with MDS, the study aims to uncover the role of TET1-S in disrupting normal blood cell formation. This could lead to new insights into the diagnosis and treatment of these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Myelodysplastic Syndrome or other related blood cancers.
Not a fit: Patients with solid tumors or those not diagnosed with blood cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential new treatments for patients with Myelodysplastic Syndrome and related blood cancers.
How similar studies have performed: While the role of TET proteins in cancer has been studied, the specific focus on the TET1 short isoform in MDS is a novel approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Qian, Zhijian — University of Florida
- Study coordinator: Qian, Zhijian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.